Embed Size (px)
Citation preview
Trends in Usage of Non-Opioid Analgesics inGeneral Practice in England
0
20,000,000
40,000,000
60,000,000
80,000,000
100,000,000
120,000,000
140,000,000
160,000,000
180,000,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
ADQ
s
Paracetamol Paracetamol combinations Aspirin Others
If no ADQ is available, the DDD has been used instead.
© Copyright NHSBSA 2008
Trends in Spending on Non-Opioid Analgesics inGeneral Practice in England
0
10,000,000
20,000,000
30,000,000
40,000,000
50,000,000
60,000,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
NIC
(£)
Paracetamol Paracetamol combinations Aspirin Others
© Copyright NHSBSA 2008
Trends in Usage of Paracetamol and Paracetamol Combinations in General Practice in England
0
20,000,000
40,000,000
60,000,000
80,000,000
100,000,000
120,000,000
140,000,000
160,000,000
180,000,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
ADQ
s
Paracetamol + Codeine (Co-codamol) Paracetamol
Paracetamol + Dihydrocodeine (Co-dydramol) Paracetamol + Dextropropoxyphene (Co-proxamol)
N.B. If no ADQ is available, the DDD has been used instead.
© Copyright NHSBSA 2008
Trends in Spending on Paracetamol and Paracetamol Combinations in General Practice in England
0
10,000,000
20,000,000
30,000,000
40,000,000
50,000,000
60,000,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08Quarter to
NIC
(£)
Paracetamol + Codeine (Co-codamol) Paracetamol
Paracetamol + Dihydrocodeine (Co-dydramol) Paracetamol + Dextropropoxyphene (Co-proxamol)
© Copyright NHSBSA 2008
Trends in Prescribing of Co-codamol Low/High Strength in General Practice in England
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
4,000,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
Item
s
Co-codamol Low Co-codamol High
© Copyright NHSBSA 2008
Trends in Spending on Co-codamol Low/High Strength in General Practice in England
0
5,000,000
10,000,000
15,000,000
20,000,000
25,000,000
30,000,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
NIC
(£)
Co-codamol Low Co-codamol High
© Copyright NHSBSA 2008
Trends in Prescribing of Opioid Analgesics inGeneral Practice in England
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
4,000,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
Item
s
Tramadol Dihydrocodeine Codeine Morphine
Fentanyl Oxycodone Buprenorphine Others
© Copyright NHSBSA 2008
Trends in Spending on Opioid Analgesics inGeneral Practice in England
0
10,000,000
20,000,000
30,000,000
40,000,000
50,000,000
60,000,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
NIC
(£)
Tramadol Dihydrocodeine Codeine Morphine
Fentanyl Oxycodone Buprenorphine Others
© Copyright NHSBSA 2008
Trends in Prescribing of Drugs to Treat Migrainein General Practice in England
0
100,000
200,000
300,000
400,000
500,000
600,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
Item
s
5HT1 agonists Analgesics with anti-emetics and Tolfenamic Acid Others
© Copyright NHSBSA 2008
Trends in Spending on Drugs to Treat Migrainein General Practice in England
0
2,000,000
4,000,000
6,000,000
8,000,000
10,000,000
12,000,000
14,000,000
16,000,000
18,000,000
20,000,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
NIC
(£)
5HT1 agonists Analgesics with anti-emetics and Tolfenamic Acid Others
© Copyright NHSBSA 2008
Trends in Usage of 5HT1 agonists in General Practice in England
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
ADQ
s
Sumatriptan Naratriptan Zolmitriptan Rizatriptan Others
If no ADQ is available, the DDD has been used instead
© Copyright NHSBSA 2008
Trends in Spending on 5HT1 agonists in General Practice in England
0
2,000,000
4,000,000
6,000,000
8,000,000
10,000,000
12,000,000
14,000,000
16,000,000
18,000,000
20,000,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
NIC
(£)
Sumatriptan Naratriptan Zolmitriptan Rizatriptan Others
© Copyright NHSBSA 2008
Trends in Prescribing of Sumatriptan by Formulationin General Practice in England
0
20,000
40,000
60,000
80,000
100,000
120,000
140,000
160,000
180,000
200,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
Item
s
Tab Injection Nasal Spray
© Copyright NHSBSA 2008
Quantities of Sumatriptan 50mg Tabs Prescribedin General Practice in England (Quarter to March 2008)
0
10,000
20,000
30,000
40,000
50,000
60,000
70,000
1 to 6 7 to 12 13 to 18 19 to 24 >25
Quantities on Prescription
Item
s
© Copyright NHSBSA 2008
Quantities of Sumatriptan 100mg Tabs Prescribedin General Practice in England
0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
1 to 6 7 to 12 13 to 18 19 to 24 25 and over
Quantities on prescription
Item
s
Qtr Jun 07 Qtr Sep 07 Qtr Dec 07 Qtr Mar 08
© Copyright NHSBSA 2008
Trends in Prescribing of and Spending on Pizotifen in General Practice in England
0
20,000
40,000
60,000
80,000
100,000
120,000
140,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
Item
s
£0
£100,000
£200,000
£300,000
£400,000
£500,000
£600,000
£700,000
£800,000
£900,000
£1,000,000
NIC
(£)
Items NIC (£)
© Copyright NHSBSA 2008
Trends in Prescribing of and Spending on Gabapentin in General Practice in England
0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
400,000
450,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
Item
s
£0
£2,000,000
£4,000,000
£6,000,000
£8,000,000
£10,000,000
£12,000,000
£14,000,000
£16,000,000
£18,000,000
NIC
(£)
Items NIC (£)
© Copyright NHSBSA 2008
Trends in Prescribing of and Spending on Pregabalin in General Practice in England
0
50,000
100,000
150,000
200,000
250,000
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
Item
s
£0
£2,000,000
£4,000,000
£6,000,000
£8,000,000
£10,000,000
£12,000,000
£14,000,000
£16,000,000
£18,000,000
NIC
(£)
Items NIC (£)
© Copyright NHSBSA 2008
Trends in Prescribing of NSAIDs in General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
Item
s
Diclofenac Ibuprofen Naproxen Meloxicam Rofecoxib Celecoxib Etoricoxib Others
© Copyright NHSBSA 2008
Trends in Spending on NSAIDs in General Practice in England
0
10,000,000
20,000,000
30,000,000
40,000,000
50,000,000
60,000,000
70,000,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
NIC
(£)
Diclofenac Ibuprofen Naproxen Meloxicam Rofecoxib Celecoxib Etoricoxib Others
© Copyright NHSBSA 2008
Pie Chart Showing the Breakdown of NSAIDs Prescribing (% of Items) in General Practice in England (Quarter to March 2008)
Celecoxib3%
Etoricoxib3%
Mefenamic Acid2%
Others2%
Etodolac2%
Indometacin2%
Meloxicam6%
Naproxen9%
Ibuprofen26%
Diclofenac45%
© Copyright NHSBSA 2008
Pie Chart showing the Breakdown of NSAIDs Spending (% of Spending)in General Practice in England (Quarter to March 2008)
Mefenamic Acid3%
Etodolac5%
Indometacin2%
Meloxicam5%
Others6%
Naproxen7%
Ibuprofen10%
Etoricoxib11%
Celecoxib12%
Diclofenac39%
© Copyright NHSBSA 2008
Trends in Prescribing of Cyclo-oxygenase-2 Selective Inhibitorsin General Practice in England
0
200,000
400,000
600,000
800,000
1,000,000
1,200,000
1,400,000
1,600,000
1,800,000
2,000,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
Item
s
Meloxicam Rofecoxib Celecoxib Etoricoxib Etodolac Others
© Copyright NHSBSA 2008
Trends in Spending on Cyclo-oxygenase-2 Selective Inhibitors in General Practice in England
0
5,000,000
10,000,000
15,000,000
20,000,000
25,000,000
30,000,000
35,000,000
40,000,000
45,000,000
50,000,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
NIC
(£)
Meloxicam Rofecoxib Celecoxib Etoricoxib Etodolac Others
© Copyright NHSBSA 2008
Trends in Prescribing of Local Corticosteroid Injections in General Practice in England
0
20,000
40,000
60,000
80,000
100,000
120,000
140,000
160,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
Item
s
Methylprednisolone Acetate Triamcinolone Hydrocortisone Acetate Prednisolone Acetate
© Copyright NHSBSA 2008
Trends in Spending on Local Corticosteroid Injections in General Practice in England
0
100,000
200,000
300,000
400,000
500,000
600,000
700,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
NIC
(£)
Methylprednisolone Acetate Triamcinolone Hydrocortisone Acetate Prednisolone Acetate
© Copyright NHSBSA 2008
Trends in Prescribing of DMARDs in General Practice in England
0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
400,000
450,000
500,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
Item
s
Methotrexate Hydroxychloroquine Leflunomide Penicillamine Others
© Copyright NHSBSA 2008
Trends in Spending on DMARDs in General Practice in England
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
4,000,000
4,500,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
NIC
(£)
Methotrexate Hydroxychloroquine Leflunomide Penicillamine Others
© Copyright NHSBSA 2008
Quantities of Methotrexate 2.5mg Tablets Prescribed inGeneral Practice in England (Quarter to March 2008)
0
10,000
20,000
30,000
40,000
50,000
60,000
1 to 4
5 to 8
9 to 12
13 to 16
17 to 20
21 to 24
25 to 28
29 to 32
33 to 36
37 to 40
41 to 44
45 to 48
49 to 52
53 to 56
57 to 60
61 to 64
65 to 68
69 to 72
73 to 76
77 to 80
81 to 84
85 to 88
89 to 92
93 to 96
97 to 100
> 100
Quantities on Prescriptions
Item
s
© Copyright NHSBSA 2008
Trends in Prescribing of and Spending onHyaluronic Acid/Sodium Hyaluronate Injections
in General Practice in England
0
100
200
300
400
500
600
700
800
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
Item
s
£0
£5,000
£10,000
£15,000
£20,000
£25,000
£30,000
£35,000
£40,000
NIC
(£)
Items NIC (£)
© Copyright NHSBSA 2008
Trends in Prescribing of Topical NSAIDsin General Practice in England
0
100,000
200,000
300,000
400,000
500,000
600,000
700,000
800,000
900,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
Item
s
Ibuprofen Diclofenac Felbinac Piroxicam Ketoprofen Benzydamine
© Copyright NHSBSA 2008
Trends in Spending on Topical NSAIDsin General Practice in England
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
4,000,000
4,500,000
5,000,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
NIC
(£)
Ibuprofen Diclofenac Felbinac Piroxicam Ketoprofen Benzydamine
© Copyright NHSBSA 2008
Trends in Prescribing of Topical Rubefacientsin General Practice in England
0
200,000
400,000
600,000
800,000
1,000,000
1,200,000
1,400,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
Item
s
Topical NSAIDs Movelat® Capsaicin Others
© Copyright NHSBSA 2008
Trends in Spending on Topical Rubefacientsin General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
8,000,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
NIC
(£)
Topical NSAIDs Movelat® Capsaicin Others
© Copyright NHSBSA 2008
Trends in Prescribing of Glucosamine in General Practice in England
0
50,000
100,000
150,000
200,000
250,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
Item
s
These figures may exclude some proprietary preparations containing Glucosamine
© Copyright NHSBSA 2008
Trends in Spending on Glucosamine in General Practice in England
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
Mar-03
Jun-03
Sep-03
Dec-03
Mar-04
Jun-04
Sep-04
Dec-04
Mar-05
Jun-05
Sep-05
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Quarter to
NIC
(£)
These figures may exclude some proprietary preparations containing Glucosamine
© Copyright NHSBSA 2008
